Time to read
1 minute
Read so far

PI3K signalling pathway offers potential new therapeutic strategy for obesity

Tue, 11/17/2020 - 10:56
Posted in:

Researchers led by MedUni Vienna have discovered the signalling pathways responsible for the development of a valuable type of adipose tissue macrophage (ATM) in obesity, which prevents lipotoxicity, the process whereby fat molecules are deposited in non-adipose tissues. In the study, ‘The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages’, published in Nature Metabolism, the researchers, including some from CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences) and the University of Graz, specifically studied the PI3K signalling pathway. This is a major metabolic regulator, since it regulates fat storage and plays a major role in the cellular reaction to the hormone insulin. In obesity, diminished insulin action or insulin resistance leads to type II diabetes, which is linked to high blood glucose levels.

"The key role of PI3K in metabolic processes is proven but its role in adipose tissue macrophages was hitherto unclear," explained Dr Gernot Schabbauer from the Institute of Vascular Biology and Thrombosis Research at MedUni Vienna's Center for Physiology and Pharmacology and senior author of the study, who has been studying the PI3K signalling pathway in immune cells for several years now.

Using techniques such as multicolour flow cytometry, lipidomics, cellular respiration tests and several animal models, the scientists discovered that sustained activity of the PI3K signalling pathway can tip the balance within macrophages for the better: this notably produces specialised ATMs, which are characterized by increased numbers of MARCO (macrophage receptor with collagenous structure) scavenger receptors on their surface.

"We discovered that these MARCO-expressing ATMs are professional lipid scavengers. These cells absorb fat MARCO-dependently and break it down, thereby preventing it from finding its way into the bloodstream," added Andrea Vogel, co-lead author of the study and PhD student in immunology at MedUni Vienna.

"Metabolic syndrome and lipotoxicity are characteristic features of obesity. Our work indicates that a higher lipid intake and improved energy metabolism of the ATMs helps to maintain systemic metabolic health,” said Dr Omar Sharif, co-senior author of the study. “This can have far-reaching impacts for a number of metabolic diseases."

Subsequent studies will now be conducted to establish whether PI3K signalling can also have a lasting influence on the ATM population in humans as well.

 "Although moderate inhibition of PI3K has already been discussed as a therapeutic strategy for treating metabolic diseases, our data point to potential unexpected side-effects. These might include altered blood lipid levels, caused by the reduced fat absorption of the ATMs," concluded Schabbauer.